Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

3D models may speed up kidney surgery

NCT ID NCT06056505

Symptom relief Sponsor: University of Leipzig Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether using a 3D model of a patient's kidney before surgery could shorten the time needed for robotic-assisted partial nephrectomy (removing a kidney tumor). 370 adults with small kidney tumors took part. The goal was to see if better planning with 3D imaging leads to fewer complications and better outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

370 people

The number who actually took part.

Started

Oct 2023

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with kidney tumours ≤ 7cm and planned robotic-assisted partial nephrectomy with the DaVinci Surgical System * CT scan with contrast medium available * Age ≥ 18 years * Written informed consent Exclusion Criteria: * History of surgery on affected kidney (e.g., partial nephrectomy, pyeloplasty, kidney cyst deroofing, percutaneous nephrolitholapaxy, radiofrequency ablation) * Clinical suspicion of metastases (stage cN1/cM1) * Horseshoe kidney * Previous malignancy with ongoing or planned nephrotoxic chemotherapy * Multifocal kidney tumour * Von Hippel-Lindau syndrome and other hereditary kidney cancer syndromes * Patient is immunosuppressed (e.g., organ transplantation, leukaemia) * Tumor thrombus in Vena renalis or Vena cava inferior * Severe cognitive impairment * Pregnancy or lactation or women with desire for children * Patients under legal supervision or guardianship * Unable to give informed consent or suspected lack of compliance * Patients who decline data collection and storage for the main study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Kidney tumor are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

kidney neoplasm renal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Kidney tumor

Contacts and locations

Locations

  • Helios Universitätsklinikum Wuppertal, Klinik für Urologie und Kinderurologie

    Wuppertal, 42283, Germany

  • Leipzig University, Department of Urology

    Leipzig, Saxony, 4103, Germany

  • Sana Klinikum Borna, Klinik für Urologie

    Borna, 04552, Germany

  • St. Antonius-Hospital Gronau, Klinik für Urologie, Kinderurologie und Urologische Onkologie

    Gronau, 48599, Germany

  • Universitätsklinikum Bonn, Klinik und Poliklinik für Urologie und Kinderurologie

    Bonn, 53127, Germany

  • Universitätsklinikum Carl Gustav Carus Dresden, Klinik und Poliklinik für Urologie

    Dresden, Saxony, 01307, Germany

  • Universitätsklinikum Magdeburg, Klinik für Urologie, Uroonkologie, robotergestützte und fokale Therapie

    Magdeburg, 39120, Germany

  • Universitätsklinikum des Saarlandes - Homburg/Saar, Klinik für Urologie und Kinderurologie

    Homburg, 66421, Germany

  • Universitätsmedizin Mainz, Klinik und Poliklinik für Urologie und Kinderurologie

    Mainz, 55131, Germany

  • Universitätsmedizin Mannheim, Klinik für Urologie und Urochirurgie

    Mannheim, 68167, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.